v3.26.1
Income Taxes - Components of the Company's deferred tax assets and liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Net operating loss carryforwards $ 65,455 $ 29,605
Capitalized research and development 30,641 39,716
Research and development tax credits 25,737 14,292
Stock-based compensation 10,017 4,016
Royalty obligation 22,492  
Milestone payments 46,697 442
Accruals 3,074 1,886
Other 817 901
Total deferred tax assets 204,930 90,858
Valuation allowance (203,870) (90,295)
Deferred tax assets, net of valuation allowance 1,060 563
Deferred tax liabilities:    
Prepaids and other (1,060) (563)
Total deferred tax liabilities $ (1,060) $ (563)